NA
BMY icon

Nautilus Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Nautilus Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$755K Sell
12,092
-253
-2% -$16K 0.46% 64
2026
Q2 		$711K Buy
12,345
+4,688
+61% +$269K 0.42% 69
2026
Q1 		$464K Sell
7,657
-76
-1% -$4.43K 0.32% 88
2025
Q4 		$417K Sell
7,733
-1,292
-14% -$62.2K 0.27% 102
2025
Q3 		$407K Sell
9,025
-472
-5% -$22K 0.27% 105
2025
Q2 		$440K Sell
9,497
-149
-2% -$7.31K 0.32% 85
2025
Q1 		$588K Sell
9,646
-100
-1% -$5.83K 0.49% 63
2024
Q4 		$551K Buy
+9,746
New +$545K 0.44% 67

Other funds holding BMY

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 13.32% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Nautilus Advisors's BMY Position: Q3 2026 in Review

Nautilus Advisors reduced its Bristol-Myers Squibb (BMY) stake by 2% in Q3 2026, selling an estimated $16K and leaving 12,092 shares worth $755K. The position accounts for 0.46% of the portfolio, ranked #64.

Nautilus Advisors first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 129 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Nautilus Advisors held 12,092 shares of Bristol-Myers Squibb worth $755K as of Q3 2026.
  • Nautilus Advisors sold 253 Bristol-Myers Squibb shares in Q3 2026, an estimated $16K.
  • Bristol-Myers Squibb made up 0.46% of Nautilus Advisors's portfolio in Q3 2026, its #64 holding.
  • Nautilus Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • 129 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Nautilus Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.